Get the Stockscreener App
0.5001
6.65%
-0.0356
After Hours:
.50
-0.000100
-0.02%
Optinose Inc stock is traded at $0.5001, with a volume of 807.51K.
It is down -6.65% in the last 24 hours and down -33.32% over the past month.
OptiNose Inc is a specialty pharmaceutical company focuses on the development and commercialization of products for patients treated by ear, nose, and throat (ENT), and allergy specialists. Its first commercial product, XHANCE (fluticasone propionate) nasal spray, 93 microgram (mcg), is a therapeutic utilizing the proprietary Exhalation Delivery System (EDS) that delivers a topically-acting corticosteroid for the treatment of chronic rhinosinusitis with and without nasal polyps.
See More
Previous Close:
$0.5357
Open:
$0.5452
24h Volume:
807.51K
Relative Volume:
1.23
Market Cap:
$75.43M
Revenue:
$70.99M
Net Income/Loss:
$-35.48M
P/E Ratio:
-1.0002
EPS:
-0.5
Net Cash Flow:
$-20.86M
1W Performance:
+4.19%
1M Performance:
-33.32%
6M Performance:
-53.26%
1Y Performance:
-59.99%
1-Day Range:
$0.46
$0.5655
1-Week Range:
$0.46
$0.5766
52-Week Range:
$0.321
$2.10
Optinose Inc Stock (OPTN) Company Profile
Name
Optinose Inc
Sector
Phone
267-364-3500
Address
777 TOWNSHIP LINE ROAD, YARDLEY, PA
Compare OPTN with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
OPTN
Optinose Inc
|
0.5001 | 75.43M | 70.99M | -35.48M | -20.86M | -0.32 |
|
ZTS
Zoetis Inc
|
175.25 | 79.07B | 9.15B | 2.43B | 2.31B | 5.32 |
|
HLN
Haleon Plc Adr
|
9.66 | 43.68B | 14.26B | 1.55B | 0 | 0.3383 |
|
TAK
Takeda Pharmaceutical Co Adr
|
13.62 | 43.18B | 30.27B | 1.93B | 3.45B | 0.6044 |
|
TEVA
Teva Pharmaceutical Industries Ltd Adr
|
16.78 | 19.01B | 16.77B | -959.00M | 1.37B | -0.85 |
|
VTRS
Viatris Inc
|
13.09 | 15.62B | 15.05B | -883.30M | 1.89B | -0.74 |
Optinose Inc Stock (OPTN) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Mar-11-24 | Initiated | H.C. Wainwright | Buy |
| Aug-21-23 | Initiated | Lake Street | Buy |
| Oct-21-22 | Resumed | Jefferies | Buy |
| Apr-07-21 | Resumed | RBC Capital Mkts | Outperform |
| Dec-18-19 | Initiated | Cowen | Outperform |
| Aug-08-18 | Initiated | Cantor Fitzgerald | Overweight |
View All
Optinose Inc Stock (OPTN) Latest News
OptiNose, Inc. (NASDAQ:OPTN) Might Not Be As Mispriced As It Looks After Plunging 31% - Simply Wall St
91,084 Shares in OptiNose, Inc. (NASDAQ:OPTN) Acquired by GSA Capital Partners LLP - Defense World
Stonepine Capital Management, LLC Increases Stake in OptiNose Inc - GuruFocus.com
OptiNose (OPTN) Reports Break-Even Earnings for Q3 - MSN
OptiNose (STU:0OP) Owner Earnings per Share (TTM) : -0.31 (As of Sep. 2024) - GuruFocus.com
Optinose to Announce Q3 2024 Financial Results with Investor Call - MSN
OptiNose (STU:0OP) 5-Year EBITDA Growth Rate : 41.10% (As of Sep. 2024) - GuruFocus.com
OptiNose stock plunges to 52-week low at $0.37 amid market challenges - Investing.com
FY2024 EPS Estimates for OptiNose Increased by HC Wainwright - Defense World
Earnings Release: Here's Why Analysts Cut Their OptiNose, Inc. (NASDAQ:OPTN) Price Target To US$3.50 - Simply Wall St
OptiNose, Inc. (NASDAQ:OPTN) Just Reported, And Analysts Assigned A US$3.50 Price Target - Yahoo Finance
FY2024 EPS Estimates for OptiNose Raised by HC Wainwright - MarketBeat
Great Point Partners LLC Bolsters Position in OptiNose Inc - GuruFocus.com
HC Wainwright Reaffirms Buy Rating for OptiNose (NASDAQ:OPTN) - Defense World
OptiNose Third Quarter 2024 Earnings: EPS: US$0.002 (vs US$0.083 loss in 3Q 2023) - Yahoo Finance
Optinose stock target down as analyst cites challenges in Xhance sales guidance - Investing.com UK
Optinose Reports Q3 2024 Financial Results, Highlights XHANCE Performance - MyChesCo
OptiNose (NASDAQ:OPTN) Given Buy Rating at HC Wainwright - MarketBeat
OptiNose, Inc. (NASDAQ:OPTN) Q3 2024 Earnings Call Transcript - Insider Monkey
OptiNose Inc (OPTN) Q3 2024 Earnings Call Highlights: Revenue Gr - GuruFocus.com
OptiNose Inc (OPTN) Q3 2024 Earnings Call Highlights: Revenue Growth Amid Revised Guidance - Yahoo Finance
FMR LLC's Strategic Acquisition of OptiNose Inc Shares - GuruFocus.com
OptiNose Inc (OPTN) Quarterly 10-Q Report - Quartzy
OptiNose stock hits 52-week low at $0.63 amid market challenges - Investing.com
Optinose Reports Third Quarter 2024 Financial Results and Recent Operational Highlights - The Manila Times
Optinose Slashes 2024 Revenue Guidance Despite Q3 Growth; XHANCE Sales Up 3% | OPTN Stock News - StockTitan
OptiNose Inc (OPTN) Q3 2024 Earnings Report Preview: What To Exp - GuruFocus.com
OptiNose (OPTN) Scheduled to Post Earnings on Tuesday - MarketBeat
Optinose (OPTN) Sets Q3 2024 Earnings Call for November 12What to Expect | OPTN Stock News - StockTitan
Optinose Announces Reporting Date for Third Quarter 2024 Financial Results - GlobeNewswire
Intranasal Drug and Vaccine Delivery Market is Expected to Soar - openPR
Head to Head Review: OPKO Health (NASDAQ:OPK) vs. OptiNose (NASDAQ:OPTN) - Defense World
Insiders In OptiNose Left Out From 19% Price Rise After Disposing Stock - Simply Wall St
Positive week for OptiNose, Inc. (NASDAQ:OPTN) institutional investors who lost 24% over the past year - Yahoo Finance
Rosalind Advisors, Inc. Expands Stake in OptiNose Inc - GuruFocus.com
Optinose Grants Stock Options to Attract New Talent - MSN
OptiNose faces potential Nasdaq delisting over share price - Investing.com India
OptiNose faces potential Nasdaq delisting over share price By Investing.com - Investing.com Australia
Optinose Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - The Manila Times
Squarepoint Ops LLC Has $178,000 Position in OptiNose, Inc. (NASDAQ:OPTN) - Defense World
OptiNose Inc (OPTN) Q2 2024 Earnings Call Highlights: Revenue Growth and Strategic Shifts Amid ... - Yahoo Finance
Optinose Appoints Terry Kohler as Chief Financial Officer - MyChesCo
OptiNose Names Terry Kohler New CFO with Incentive Grant - TipRanks
Optinose names Terry Kohler as new CFO - Investing.com
Optinose Names Terry Kohler as CFO - MarketWatch
Optinose Inc Stock (OPTN) Financials Data
Revenue
Net Income
Cash Flow
EPS
1.11%
0.61%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):